Hubert Bernauer1, Anja Schlör2,3, Josef Maier1,4, Katja Hanack2,3, Norbert Bannert5, and Daniel Ivanusic5§
1ATG:biosynthetics GmbH, Weberstraße 40, 79249 Merzhausen, Germany
2new/era/mabs GmbH, August-Bebel-Str. 89, 14482 Potsdam, Germany
3Institute for Biology and Biochemistry, University of Potsdam, Karl-Liebknechtstr. 24-25, 14476 Potsdam, Germany
4IStLS, Härlestr. 24/1, 78727 Oberndorf a.N., Germany
5Sexually transmitted bacterial pathogens and HIV (FG18), Robert Koch-Institute, Nordufer 20, 13353 Berlin, Germany.
§Correspondence to: Daniel Ivanusic (daniel.ivanusic@web.de)
David Mu
© 2024 by the authors. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PubMed Central: 11063790
PubMed: 38698909